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Abstract
Background: For years, there have been various discussion of Calorie Restriction (CR) and low carbohydrate diet (LCD). 
We have continued clinical research of CR and LCD so far. 
Patient and Method: The patient was 72-year-old female with type 2 diabetes mellitus (T2DM). At first visit, she showed 
BMI 29.5, postprandial 120 min of blood glucose 548 mg/dl, HbA1c 18.0%, Hb 11.4 g/dL, GOT 29 IU/mL, r-GTP 36 IU/mL, 
Cre 1.0 mg/dL, TG 194 mg/dL, LDL 161 mg/dL. Serum C-peptide radioimmunoactivity (CPR) 5.4 ng/mL, urinary protein 
24 mg/dL.
Results: We have treated her by standard LCD meal, including 26% of carbohydrate with 1400kcal per day. She could 
continue LCD successfully and showed the decreased data as follows: HbA1c 18.0% to 7.8%, blood glucose 548 mg/dL to 
154 mg/dL, proteinuria 24 mg/dL to 3 mg/dL, weight 72 kg to 65 kg for some months.
Discussion and Conclusion: LCD showed clinical efficacy in several biomarkers. Patient applied standard-LCD method, 
including 26% of carbohydrate with 1400 kcal per day, which would bring decreased HbA1c, glucose, proteinuria and 
weight to the actual degree. These data would become basal reference and would bring further research development in 
the future.
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Introduction
Recently, there has been serious medical and social problems worldwide. It is acute increase of type 2 diabetes mellitus 
(T2DM). The number of T2DM was approximately 385 million in 2014, and will increase to 592 million by 2035 [1,2]. Con-
sequently, effective and successful treatment for T2DM has been in discussion for years, including diet therapy, exercise 
therapy, anti-diabetic agents and insulin therapy [3]. 
In response to diabetic problems, diabetic societies in several countries have summarized their guidelines so far. Some 
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changes of the guideline were found about the goal of the 
therapy for the diabetes. There was a proposal of joint al-
gorithm from the European Diabetes Society (EASD) 2012 
[4]. After that, the official comment was presented from the 
American College of Physicians (ACP) in 2017 [5]. It includ-
ed a new interpretation for the standard level of the goal 
for HbA1c [6]. The important difference was the value for 
HbA1c in most T2DM patients, which was to be 7% or more 
and less than 8%. It showed a large impact for other dia-
betic societies, because of the discrepancy of ideal value as 
before. This impact was so large to influence much for sev-
eral diabetic societies. Against the presentation of ACP, ADA 
announced an objection at once [3]. Consequently, diabet-
ic management has been in discussion with some diabetic 
guidelines.
On the other hand, there have been discussion of nutri-
tional therapy for years. They include the comparison with 
Calorie restriction (CR) and Low Carbohydrate Diet (LCD). 
Originally, Bernstein and Atkins started LCD in 1990’ in 
Western and European countries [7,8]. After that, LCD has 
been gradually known and popular, and clinical efficacy of 
LCD for weight reduction and normalizing glucose variabil-
ity has been reported so far. Then, LCD has revealed rath-
er predominant effect in comparison with low fat diet and 
Mediterranean diet from the Dietary Intervention Random-
ized Controlled Trial (DIRECT) study [9,10]. There are con-
tinuing discussion about CR and LCD, and the latter would 
be shown in the light of various predominant efficacy in the 
clinical several situations [11,12]. 
In Japan, the authors and colleagues have initiated LCD 
through various opportunities [13]. We have continued to 
develop LCD movement using simple method of LCD in 3 
types, which are super LCD, moderate LCD and petite LCD 
meals [14,15]. 
In this report, we would present clinical situation of the 
severe degree of T2DM, and the clinical application of LCD 
for the patient. The response of LCD would be shown by the 
decreasing value of HbA1c, blood glucose variability and 
weight reduction during several months.
Case Report
The patient was 72-year-old female who has been for-
merly diagnosed as type 2 diabetes mellitus (T2DM) at the 
age of 65. At that time, she was explained to have diabetic 
tendency with the necessary treatment of diet therapy, and 
with no need to start anti-diabetic agent.
After that, she has not have remarkable health problems. 
In November of the year 201x, she developed symptoms 
of upper respiratory infection and visited near ambulato-
ry clinic. By blood glucose rapid measurement kit, she was 
proved to have diabetic states due to extremely elevated 
blood glucose level. Then, she was transferred to our dia-
betic specialty clinic for further evaluation and treatment. 
On physical examination, she showed 156 cm in height, 
72 kg in weight, BMI 29.5 at first visit. Her vitals and con-
sciousness are normal, and lung, heart, abdomen and neu-
rological findings were unremarkable. Chest X-P and EKG 
showed no remarkable changes. She showed moderate fatty 
liver by the examination of abdominal CT scan. 
Laboratory data showed the following data: postprandial 
glucose-120 min 548 mg/dl, HbA1c was 18.0%, Hb 11.4 g/
dL, GOT 29 IU/mL, GPT 28 IU/mL, r-GTP 36 IU/mL, BUN 19 
mg/dL, Cre 1.0 mg/dL, TG 194 mg/dL, LDL 161 mg/dL. Se-
rum C-peptide radioimmunoactivity (CPR) was 5.4 ng/mL 
(0.8 – 2.5). There was elevated value of urinary protein as 
24 mg/dL (< 10). 
From these data above, the patient was diagnosed to have 
severe type 2 diabetes mellitus, obesity and fatty liver. We 
consulted about the diabetic treatment such as diet therapy, 
exercise and anti-diabetic agents. She has been working in 
the restaurant for years, and her life style has been regular. 
For the proposal of treatment of LCD, she judged that LCD 
can be successfully continued for several months with her 
strong mind to be relieved from diabetic states.
The practical method of the diet therapy was standard LCD 
method. It has 26% of carbohydrate from the calorie ratio 
and 1400kcal per day. In other word, it has 364 kcal (1400 
x 0.26 = 364) per day, and equals to 91g (364/4 =91) of car-
bohydrate intake a day. 
Clinical course of the case is shown in in (Figure 1). Just 
after the diagnosis of severe diabetic state with extremely 
elevated HbA1c and blood glucose, we start the diet ther-
apy of LCD. She had continued LCD for several weeks suc-
cessfully. HbA1c value was decreased from 18.0% to 7.8% 
in 4 months. Similarly, blood glucose was decreased from 
548 mg/dL to 154 mg/dL in 2 months. As to proteinuria, its 
concentration in urine was decreased from 24 mg/dL to 3 
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mg/dL in 8 months. Regarding the body weight, she showed 
7 kg of weight reduction from 72 kg to 65 kg for 4 months.
Figure 1: Clinical progress course of the case (72-year-
old female with T2DM).
Ethical considerations
This report was conducted in compliance with the ethical 
principles of the Declaration of Helsinki. Moreover, it was 
also with Japan’s Act on the Protection of Personal Informa-
tion along with the Ministerial Ordinance on Good Clinical 
Practice (GCP) for Drug (Ordinance of Ministry of Health 
and Welfare No. 28 of March 27, 1997). 
As for current research, we made an ethical committee 
in the Yoshinogawa Hospital including the president, the 
vice-president, the head-nurse of the nursing department, 
director of the Pharmaceutical department, director of the 
administration and expert in the mmedical and legal spe-
cialty. We discussed about this report and concluded that 
this is valid and agreed with all members without any prob-
lems. Further, informed consents and written paper agree-
ments have been obtained from the subject. 
Discussion
The author and colleague researchers have continued clin-
ical experience and research of CR and LCD for years. We 
have established Japanese LCD promotion association (JL-
CDPA) and developed LCD in Japan by various seminars, 
lectures, textbooks, presentation of medical congress [15].
In our previous report, there were clinical experience for 
LCD with almost 2700 cases [14,16]. We found the weight 
reduction degree that more than 10% was observed in 26% 
of subjects, and that more than 2.5% was observed in 79% 
of subjects, suggesting clinical effect of LCD for reducing 
body weight. 
The beneficial and characteristic methods include the 
following three pattern of LCD as follows [15,17]: 1) su-
per-LCD: strictly limited in 3 meals, 2) standard-LCD: limit-
ed in 2 meals a day, 3) petit-LCD: limited in 1 meal a day. In 
these three methods, the carbohydrate ratio in the light of 
calorie calculation is 12%, 26%, 40%, respectively [15,17].
 As to the definition of LCD, Feinman and Bernstein have 
classified nutrition therapy into several categories. [18] 
They are 
i) Very low-carbohydrate ketogenic diet (VLCKD): Carbohy-
drate, 20–50 g/d or < 10% of the 2000 kcal/d diet.
ii) Low-carbohydrate diet: < 130 g/d or < 26 % total energy.
iii) Moderate-Carbohydrate Diet: 26 % – 45 %.
 iv) High-Carbohydrate Diet: > 45 % - 201) 
Super-LCD is included in the group of VLCKD. It contains 
12 % of carbohydrate, and 42g of carbohydrate intake with 
168 kcal, when the total calorie is standard 1400 kcal a day. 
On contrast, standard-LCD contains 26% of carbohydrate, 
and 91g of carbohydrate a day. 
Continuing Super-LCD usually makes the patient elevated 
ketone bodies and significant weight reduction [14,16]. 
Continuing ketogenic diet seems to be necessary to ob-
tain enough weight reduction [19,20]. On contrast, stan-
dard-LCD does not usually produce ketone bodies so much 
[14]. The reason is that carbohydrate intake a day would 
not be so limited, and that there are various responses of 
generating ketone bodies due to the predisposition of each 
patient.
In this report, the case has several characteristics about 
clinical manifestation. She showed extremely high HbA1c 
value and hyperglycemia. However, she has not complained 
of well-known symptoms, such as thirsty, weight loss, fa-
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tigue and so on, which are usually observed in severe de-
gree of diabetes [21].
The reason for this may be related to the lifestyle of daily 
work in the patient. She has always walked a lot, worked 
hard and carried relatively heavy things every day, in which 
she has stimulated the muscle during work on a daily basis. 
Furthermore, she applied not super-LCD method, but stan-
dard-LCD, where the rate of decrease of HbA1c and weight 
loss was observed about to this moderate degree. 
As blood glucose variability became rather normal range, 
proteinuria representing renal impairment has decreased. 
We have investigated the relationship between LCD and 
renal function [22]. Then, further research development 
would be expected in the future.
  In summary, the case in this study showed that LCD would 
be useful for improvement of HbA1c and blood glucose, 
indicating glucose variability. Furthermore, she showed 
enough weight reduction and decreased proteinuria. These 
data would become basal reference data in this area of re-
search and would bring further research development in 
the future.
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